The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis
暂无分享,去创建一个
G. Jiang | Jie Yang | Peng Zhang | A. Gusdon | A. Peng | Xiaoting Sun | Bo Wang
[1] G. Jiang,et al. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study , 2018, Journal of Cancer Research and Clinical Oncology.
[2] Eelco F. J. Meijer,et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice , 2018, Science.
[3] Z. Bago-Horvath,et al. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice , 2018, Science.
[4] V. Rusch,et al. Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[5] J. Condeelis,et al. Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway , 2016, Oncogene.
[6] Y. She,et al. Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease? , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] D. Boffa,et al. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer. , 2016, The Annals of thoracic surgery.
[8] Ping Yang,et al. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis , 2016, Oncotarget.
[9] Hisao Asamura,et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] D. Ettinger,et al. Non-Small Cell Lung Cancer, Version 6.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.
[11] K. Hemminki,et al. Metastatic sites and survival in lung cancer. , 2014, Lung cancer.
[12] M. Skobe,et al. Role of lymphatic vasculature in regional and distant metastases. , 2014, Microvascular research.
[13] A. Jemal,et al. Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[14] A. Jemal,et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. , 2012, The Lancet. Oncology.
[15] R. Osarogiagbon,et al. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer. , 2011, The Annals of thoracic surgery.
[16] R. Osarogiagbon,et al. Outcome of Surgical Resection for Pathologic N0 and Nx Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] R. Govindan,et al. Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] K. Alitalo,et al. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. , 2008, Cancer research.
[19] K. Alitalo,et al. Modulating metastasis by a lymphangiogenic switch in prostate cancer , 2007, International journal of cancer.
[20] R. Hynes,et al. Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide? , 2006, Cell cycle.
[21] M. Skobe,et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. , 2006, Cancer research.
[22] G. Watanabe,et al. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. , 2001, The Journal of thoracic and cardiovascular surgery.
[23] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[24] Frank C. Detterbeck,et al. The Eighth Edition Lung Cancer Stage Classification , 2017, Chest.
[25] H. Satoh,et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. , 2015, Molecular and clinical oncology.